The Parthenon Group, a global strategy consultancy with 300 professionals in offices around the world, has signed an agreement to combine its operations with EY.
The Swiss M&A market recorded an exceptional first half year 2014. A particular highlight was that disclosed deal volume reached a new record in Q2 2014 with the highest volume since 2008.
The annual EY biotechnology industry report, Beyond borders: unlocking value, paints a comprehensive picture of the industry’s financial position, its future challenges and ways to tackle them, strategies for unlocking value.
